trial · primary record
Thyrogen
Thyroid Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2035-11-01 |
| Primary endpoint | Comparison of the whole body and lesional 124I uptake within each patient prepared for imaging with human recombinant TSH (rhTSH) and thyroid hormone withdrawal (THW) |
| Registry ID | NCT03841617 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:23.861Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03841617
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.